Manuel
Fernández Bruno
Institut Universitari Dexeus
Barcelona, EspañaPublications in collaboration with researchers from Institut Universitari Dexeus (7)
2019
-
Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer
Journal of Thoracic Oncology, Vol. 14, Núm. 2, pp. 304-310
-
BRAF mutations classes I, II, and III in NSCLC patients included in the SLLIP trial: The need for a new pre-clinical treatment rationale
Cancers, Vol. 11, Núm. 9
-
EGFR first- and second-generation TKIs-there is still place for them in EGFR-mutant NSCLC patients
Translational Cancer Research, Vol. 8, pp. S23-S47
-
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
EBioMedicine, Vol. 39, pp. 207-214
-
PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer
Journal of Cancer Metastasis and Treatment, Vol. 5
2018
-
Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC
Translational Lung Cancer Research, Vol. 7, Núm. 6, pp. 691-702
-
Strategies for first-line immunotherapy in squamous cell lung cancer: Are combinations a game changer?
Translational Lung Cancer Research, Vol. 7, pp. S198-S201